RPGLF

Healthcare Drug Manufacturers - Specialty & Generic

Regent Pacific Group Limited

$0.01

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

1.72M

Avg Volume

EPS

-$0.02

52W High

$0.43

52W Low

$0.01

Div. Yield

0.0%

Valuation

P/B Ratio

-0.28

P/S Ratio

0.32

EV/EBITDA

64.18

EV/Revenue

1.64

Margins

Gross Margin 83.7%

Operating Margin 45.8%

Net Margin (36.1%)

EBITDA Margin 2.6%

Growth & Returns

Revenue Growth (YoY)

2125.7%

Return on Assets

2.5%

Liquidity & Leverage

Current Ratio

0.64

Quick Ratio

0.61

Total Cash

224,000

Total Debt

7.36M

About

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in the United States, Europe, and Asia Pacific. The company operates through two segments, Biopharma and Corporate Investment. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services. The company was formerly known as Endurance RP Limited and changed its name to Regent Pacific Group Limited in July 2023. Regent Pacific Group Limited was founded in 1991 and is headquartered in Central, Hong Kong.